High Cholesterol News and Research

RSS

Only half of the people with cardiovascular disease risk receive lifestyle support from GPs, study shows

A new 10-year analysis of people in England newly diagnosed with high blood pressure, high cholesterol or obesity shows only half receive lifestyle support from their GPs.

17 Feb 2022

Heart attack survivors may have a lower risk of Parkinson's disease

People who have had a heart attack may be slightly less likely than people in the general population to develop Parkinson's disease later in life, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

16 Feb 2022

Study shows the true prevalence of statin intolerance worldwide is between 6 to 10%

As many as one in two patients stop taking statins, reduce the dose or take them irregularly because they believe the cholesterol-lowering drugs cause muscle pain and other side-effects.

16 Feb 2022

More than half of women in the U.S. have poor pre-pregnancy cardiometabolic health

Only about 40% of women in the U.S. who gave birth in 2019 had good heart health prior to their pregnancy with excess weight being the major driver of poor pre-pregnancy health, followed by hypertension and diabetes, according to new research published today in a Go Red For Women spotlight issue of the American Heart Association's peer-reviewed, flagship journal Circulation.

14 Feb 2022

New class of compounds can improve multiple aspects of metabolic syndrome, mice study shows

A study in mice -; led by researchers at Washington University School of Medicine in St. Louis -; shows that a new class of compounds the scientists developed can improve multiple aspects of metabolic syndrome.

12 Feb 2022

Study highlights the importance of educational attainment for better brain health

A Finnish twin study suggests that the deteriorative effects of cardiovascular risk factors on late-life cognition are stronger in individuals with lower education compared to those with higher education.

7 Feb 2022

Brains of adults with heart-healthy lifestyle are larger and show fewer signs of injury, research finds

On imaging tests, brains were larger and showed fewer signs of injury in early to late middle-aged adults (ages 40-69 years) who had nearly ideal cardiovascular health, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health to be held in person in New Orleans and virtually, Feb. 8-11, 2022.

3 Feb 2022

Social isolation, loneliness increase cardiovascular disease risk in postmenopausal women

During the current pandemic, social distancing has been one tool used to reduce the spread of COVID-19. But data from a new study point to as much as a 27% increase in heart disease risk in postmenopausal women who experience both high levels of social isolation and loneliness.

2 Feb 2022

Immunogenicity to BNT162b2 booster in adults who had previously received inactivated COVID-19 vaccination

A new preprint available on medRxiv* demonstrates the marked improvement in the immune response when the mRNA vaccine BNT162b2, from Pfizer/BioNTech, is used for the third dose after a primary two-dose series of an inactivated whole virus vaccine.

25 Jan 2022

Scientists develop new drug delivery system for treating genetic diseases

A team of researchers led by Harvard and Broad Institute scientists has developed a new drug delivery system using engineered DNA-free virus-like particles (eVLPs) to package and deliver therapeutic levels of gene-editing proteins to animal models of disease.

22 Jan 2022

Fewer than 1 in 5 U.S. adults with Type 2 diabetes meet targets to reduce heart disease risk

Fewer than 1 in 5 adults with Type 2 diabetes in the U.S. are meeting targets to reduce heart disease risk. Fortunately, available therapies can help when combined with new approaches that address social determinants of health and other barriers to care, according to a new American Heart Association scientific statement published today in the Association's flagship journal Circulation.

10 Jan 2022

FAU researchers urge to prescribe aspirin based on benefit-to-risk not age

Recent guidelines have restricted aspirin use in the primary prevention of cardiovascular disease to patients under 70, and more recent guidance to patients under 60. Yet, the risks of heart attacks and strokes increase markedly with age.

5 Jan 2022

Erectile dysfunction medication found to intensify abdominal aortic aneurysms in mice

In a laboratory study in mice, sildenafil, a commonly used erectile dysfunction medication, was found to worsen abdominal aortic aneurysms, indicating additional research may be needed to determine if the medication may have the same effect on people, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

5 Jan 2022

Study uncovers new details behind inflammation that promotes cardiovascular disease

High cholesterol and inflammation are key drivers of heart disease, and an inflamed buildup of lipids can cut off the blood supply through a coronary artery to cause a heart attack.

24 Dec 2021

Worsening brain function linked to deep anesthesia during surgery

After surgery under general anaesthesia, older patients often experience a decline in cognitive function that can last for months or even years. This worsening brain function has been linked to deep anesthesia during surgery.

20 Dec 2021

Diversity in genetic data improves the ability to predict high cholesterol risk

Including data from people of diverse ancestries substantially improves certain genetic risk predictions in all populations, according to a study that examined the genes responsible for regulating blood cholesterol levels.

13 Dec 2021

Prescribing generic heart medications in Medicare Part D could result in substantial savings

Prescribing generic medications for heart and blood vessel diseases more frequently instead of brand-name medications in Medicare's prescription drug program, called Part D, could save more than $600 million each year in the U.S., according to new research published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

9 Dec 2021

Novel AI-based system models the progression of chronic diseases as patients age

Using artificial intelligence, a team of University at Buffalo researchers has developed a novel system that models the progression of chronic diseases as patients age.

7 Dec 2021

Aspirin use associated with raised risk of heart failure

Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition.

23 Nov 2021

Oral PCSK9-inhibitor highly effective at reducing high levels of LDL cholesterol, studies show

Results from two early clinical studies show the first version of an oral PCSK9-inhibitor cholesterol-lowering medicine was well tolerated and highly effective at reducing high levels of LDL cholesterol, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021